Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CARDIOSTEM: Validation of a Cell Expansion Automaton in Healthy Volunteers
NCT05594433Phase 1Terminated
- Sponsor
- CellProthera
- Start
- Sep 2015
- Primary completion
- Dec 2024
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of lenograstim, sponsored by CellProthera. Primary endpoint: Number of blood donation of CD34+ stem cells obtained to validate the new automaton at 5 days. Started Sep 2015; status: terminated.
02
Drugs
lenograstim
Beyond the preview
Go deeper on NCT05594433.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05594433.